X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
humans (8) 8
oncology (7) 7
animals (6) 6
emt (4) 4
epithelial-mesenchymal transition (4) 4
metastasis (4) 4
animal structures (3) 3
apoptosis (3) 3
cancer (3) 3
cell line, tumor (3) 3
female (3) 3
glycosylation (3) 3
male (3) 3
mice (3) 3
progression (3) 3
signal transduction (3) 3
up-regulation (3) 3
article (2) 2
biosynthesis (2) 2
carcinogenesis (2) 2
cell cycle (2) 2
cell proliferation (2) 2
cells (2) 2
expression (2) 2
gene (2) 2
gene expression (2) 2
growth (2) 2
heterografts (2) 2
hexosamines (2) 2
hoxa9 (2) 2
liver cancer (2) 2
liver neoplasms - pathology (2) 2
lung cancer (2) 2
metabolism (2) 2
mice, nude (2) 2
nuclear proteins - genetics (2) 2
nuclear proteins - metabolism (2) 2
o-glcnac (2) 2
phase-ii (2) 2
phosphorylation (2) 2
prostate-cancer (2) 2
prostatic neoplasms - genetics (2) 2
prostatic neoplasms - pathology (2) 2
proteins (2) 2
radiation (2) 2
radiation therapy (2) 2
research (2) 2
research article (2) 2
senescence (2) 2
survival (2) 2
tumors (2) 2
twist-related protein 1 - genetics (2) 2
twist-related protein 1 - metabolism (2) 2
a549 cells (1) 1
abridged index medicus (1) 1
acetylcysteine - pharmacology (1) 1
acorn worm (1) 1
activation (1) 1
acylation (1) 1
adult (1) 1
advanced hepatocellular-carcinoma (1) 1
amines (1) 1
amino acid motifs (1) 1
amino acid substitution (1) 1
anatomy & morphology (1) 1
angiogenesis (1) 1
animal model (1) 1
animal models (1) 1
anthracenes - pharmacology (1) 1
anti-inflammatory agents - adverse effects (1) 1
anti-inflammatory agents - therapeutic use (1) 1
anti-tnf therapy (1) 1
anti-tumor activity (1) 1
antiangiogenesis therapy (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - therapeutic use (1) 1
antioxidants - pharmacology (1) 1
antitumor necrosis factor (1) 1
apical organ (1) 1
apoptosis - drug effects (1) 1
apoptosis - radiation effects (1) 1
basic helix-loop-helix transcription factors - chemistry (1) 1
basic helix-loop-helix transcription factors - genetics (1) 1
basic helix-loop-helix transcription factors - metabolism (1) 1
bay-43-9006 (1) 1
beta-1,6-branched oligosaccharides (1) 1
beta-propeller domain (1) 1
biological products - adverse effects (1) 1
biological products - therapeutic use (1) 1
biologics (1) 1
biology (1) 1
biotechnology (1) 1
bisecting glcnac (1) 1
blotting, western (1) 1
body regions (1) 1
brain (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 4241 - 4241
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 4222 - 4222
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2016, Volume 6, p. 85
Journal Article
Cancer Research, ISSN 0008-5472, 06/2017, Volume 77, Issue 12, pp. 3181 - 3193
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4038 - 4038
BACKGROUND: Historically, one in five Hodgkin Lymphoma (HL) patients treated with bleomycin develop bleomycin pulmonary toxicity (BPT), a life-threatening... 
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 09/2019, pp. 1 - 11
One-in-five Hodgkin Lymphoma (HL) patients treated with bleomycin develop bleomycin pulmonary toxicity (BPT). Given bleomycin-omission data with negative... 
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 11/2018, Volume 128, Issue 11, pp. 4924 - 4937
Journal Article
Diseases of the Colon & Rectum, ISSN 0012-3706, 11/2019, Volume 62, Issue 11, pp. 1352 - 1362
BACKGROUND:The evidence regarding the association of preoperative biologic exposure and postoperative outcomes remains controversial for both antitumor... 
Journal Article
Neoplasia, ISSN 1476-5586, 2014, Volume 17, Issue 1, pp. 16 - 31
Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 2291 - 2291
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 1054 - 1054
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e65726
Sorafenib (SOR) is the only systemic agent known to improve survival for hepatocellular carcinoma (HCC). However, SOR prolongs survival by less than 3 months... 
UNITED-STATES | BAY-43-9006 | TUMOR PROGRESSION | ANGIOGENESIS | MULTIDISCIPLINARY SCIENCES | GROWTH | TRANSARTERIAL CHEMOEMBOLIZATION | RAF KINASE | PHASE-II | INHIBITOR | RAF/MEK/ERK PATHWAY | Niacinamide - analogs & derivatives | Gene Expression - drug effects | Apoptosis - drug effects | Apoptosis - radiation effects | Humans | Radiation Tolerance | Gamma Rays - therapeutic use | Antineoplastic Agents - therapeutic use | Liver Neoplasms - therapy | DNA Breaks, Double-Stranded - radiation effects | DNA Breaks, Double-Stranded - drug effects | Carcinoma, Hepatocellular - genetics | Carcinoma, Hepatocellular - blood supply | Liver Neoplasms - pathology | Neovascularization, Pathologic - prevention & control | Liver Neoplasms - genetics | Cell Cycle - radiation effects | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Clinical Trials as Topic | Gene Expression - radiation effects | Xenograft Model Antitumor Assays | Animals | Histones - genetics | Liver Neoplasms - blood supply | Tumor Burden - drug effects | Hindlimb - blood supply | Mice, Nude | Sorafenib | Carcinoma, Hepatocellular - pathology | Hindlimb - pathology | Cell Line, Tumor | Carcinoma, Hepatocellular - therapy | Combined Modality Therapy - methods | Mice | Histones - metabolism | Cell Cycle - drug effects | Hindlimb - metabolism | Antimitotic agents | Hepatoma | Antineoplastic agents | Radiation | Apoptosis | Biotechnology | Post-irradiation | Physicians | Brain cancer | Clinical trials | Oncology | Hepatocellular carcinoma | Cancer therapies | Delay | Cell adhesion & migration | Liver cancer | Xenografts | Cell cycle | Growth factors | Deoxyribonucleic acid--DNA | Cell survival | Decision making | Survival | Radioprotection | Medicine | Medical prognosis | Cell lines | Irradiation | Clothing industry | Immunofluorescence | Health risk assessment | Deoxyribonucleic acid | DNA
Journal Article
Cancer Research, ISSN 0008-5472, 04/2012, Volume 72, Issue 8 Supplement, pp. 2075 - 2075
Journal Article
DISEASES OF THE COLON & RECTUM, ISSN 0012-3706, 11/2019, Volume 62, Issue 11, pp. 1352 - 1362
BACKGROUND: The evidence regarding the association of preoperative biologic exposure and postoperative outcomes remains controversial for both antitumor... 
SURGERY | ILEOCOLONIC RESECTION | VEDOLIZUMAB-TREATED PATIENTS | IMMUNOSUPPRESSIVE MEDICATION | Antitumor necrosis factor | Ustekinumab | ANTI-TNF THERAPY | Crohn's disease | MONOCLONAL-ANTIBODY | CERTOLIZUMAB PEGOL | Postoperative outcomes | PREOPERATIVE INFLIXIMAB THERAPY | MAINTENANCE THERAPY | INFLAMMATORY-BOWEL-DISEASE | Biologics | Veolizumab | NECROSIS FACTOR THERAPY | GASTROENTEROLOGY & HEPATOLOGY | Follow-Up Studies | United States | Humans | Colectomy - methods | Crohn Disease - surgery | Male | Drug Monitoring - methods | Intraabdominal Infections - diagnosis | Anti-Inflammatory Agents - adverse effects | Interleukin-23 - antagonists & inhibitors | Interleukin-12 - antagonists & inhibitors | Anti-Inflammatory Agents - therapeutic use | Intraabdominal Infections - etiology | Adult | Biological Products - adverse effects | Female | Colectomy - adverse effects | Biological Products - therapeutic use | Antibodies, Monoclonal, Humanized - adverse effects | Outcome and Process Assessment, Health Care | Antibodies, Monoclonal, Humanized - therapeutic use | Postoperative Complications - epidemiology | Crohn Disease - immunology | Ustekinumab - therapeutic use | Intraabdominal Infections - epidemiology | Postoperative Complications - diagnosis | Ustekinumab - adverse effects | Crohn Disease - drug therapy | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Preoperative Period
Journal Article
Zoological Science, ISSN 0289-0003, 2010, Volume 27, Issue 2, pp. 91 - 95
When the body of P. flava is severed, the animal has the ability to regenerate its missing anterior or posterior as appropriate. We have focused on anterior... 
gill | regeneration | brain evolution | acorn worm | SEM | in-situ hybridization | animal model | Animal model | Regeneration | Gill | Brain evolution | In-situ hybridization | Acorn worm | ANIMALS | STEM-CELLS | APICAL ORGAN | ZOOLOGY | GENE | PLANARIAN REGENERATION | LARVAE | EXPRESSION | EMBRYOS | BRAIN | Animals | Regeneration - physiology | Chordata, Nonvertebrate - ultrastructure | Chordata, Nonvertebrate - physiology
Journal Article
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 2908 - 2908
Journal Article